Drug
Dsp 0337
Dsp 0337: highest development phase Phase 1, developed by Sumitomo Pharma. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Sumitomo Pharma
Trials
| Drug | Phase | Indication |
|---|---|---|
| DSP-0337 NCT03416816 | Phase 1 | Neoplasms |
Latest
No recent events.
Follow Dsp 0337 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.